Damage Control in Abdominal Trauma
|
|
|
- Rudolph Blair
- 9 years ago
- Views:
Transcription
1 Damage Control in Abdominal Trauma Steven Stylianos, MD Surgeon-in-Chief, Morgan Stanley Children s Hospital Rudolph Schullinger Professor of Surgery, Columbia University College of Physicians & Surgeons
2
3 Background NOM successful in children with severe solid organ injuries (>88% NOM in Grade IV) JPS 2000; 2002; 2008 Most failures within 6-12 hours J Trauma 2005; 2006 The challenge of teaching psychomotor skills for hemostasis of solid organ injury J Trauma 2009
4 Time to OR Pediatric Solid Organ Injury 1818 pts (7 PTC; ) 89 pts (5%) to OR Median time to OR: 3 hrs 59% within 4 hrs 76% within 12 hrs 1813 pts (NTDB; ) 120 pts (7%) to OR Median time to OR: 2.4 hrs 79% within 6 hrs 90% within 24 hrs» J Trauma 2005» J Trauma 2006
5 % Impact of Guidelines?
6 Damage Control Definition Rapid hemostasis (ligation, stenting, packing, fixation) Control contamination Temporary abdominal wall closure Resuscitation in ICU
7 Damage Control Single GSW to Lt 6 th ICS in Dallas, 1963 Diaphragm Spleen Stomach Pancreas Aorta/SMA IVC Rt Kidney Liver
8 Damage Control? 107 minutes in OR Scoop and run EBL: 6000 ml 16 units PRBC 4 liters RL Temp? Coags? ph? trauma was too great for resuscitation
9 Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall
10 Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall
11 Damage Control When? Increased emphasis on physiologic/metabolic state Triad of hypothermia, acidosis, and coagulopathy Success of damage control depends on decision prior to irreversible shock Damage control represents advanced surgical care!
12 Damage Control Strategy How? - 3 Phases Phase 1 Phase 2 Abbreviated laparotomy Control of hemorrhage and contamination Packing and temporary abdominal wall closure Aggressive ICU resuscitation Core re-warming Optimize volume/o 2 delivery Correct coagulopathy
13 Damage Control Strategy Phase 3 Planned re-operation for packing change and washout Definitive repair of injuries Abdominal wall closure
14 Damage Control Where? Any hospital; Battlefield Facilitates transfer Trauma ICU Interventional radiology ERCP
15 Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall
16 Damage Control Hemorrhage Temporary stenting Packing/tamponade Angio-embolization Recombinant FVIIa Tranexamic acid
17 Solid Organ Tract Hemorrhage Balloon Tamponade
18 Total Hepatic Vascular Occlusion
19 Lap Pad Packing
20 Lap Pad Packing
21 Abdominal Packing in Children JPS patients (age: 6d to 20y) Trauma; tumors; NEC Peri-hepatic: 64% Transfusion: 190 ml/kr All were in shock ( triad )
22 Abdominal Packing in Children JPS Use at primary OP: 68% Control of bleeding: 95% Abscess formation: 32% Survival: 82%
23 Your Patient is Bleeding Do Something!
24 Contrast blush on CT
25 Contrast blush on CT
26 Angio-Embolization
27 Splenic Embolization in Injured Children What are the selection criteria?
28 Proximal vs Distal Splenic Artery Embolization J Trauma 2011 Los Angeles Systematic/meta-analysis in adults ( ) Proximal embolization: - decreases flow - promotes clot formation - reduces infarction - without a higher re-bleed rate.
29
30 Pelvic Fracture Hemorrhage
31 Extraperitoneal Pelvic Packing
32 Pelvic Compression/Packing
33 Damage Control Topics When / How / Where? Hemorrhage Physiology Abdominal Wall
34 Damage Control Physiology Triad Hypothermia Acidosis Coagulopathy (1:1:1)
35 Coagulopathy of Trauma
36 Damage Control Triad Effects Pro-coagulant enzymes Fibrinolysis Platelet activation Platelet adhesion The Coagulopathy of Trauma J Trauma Oct 08
37 Coagulopathy in Pediatric Trauma Traumatic coagulopathy is a complex process that leads to global dysfunction of the endogenous coagulation system resulting in worse outcomes and increased mortality. Although the cause is multifactorial, it is common in severely injured patients and is driven by significant tissue injury and hypoperfusion. Viscoelastic coagulation tests (TEG /ROTEM ) have been established as a rapid and reliable method to assess traumatic coagulopathy and produce a dynamic picture of the entire coagulation process. - Curr Opin Pediatr 2014
38 Massive Transfusion Protocols Prospective, randomized trials and retrospective analyses support the use of a restrictive packed RBC transfusion policy in most clinical conditions in children. Current transfusion practices for both platelets and coagulant products (e.g., fresh-frozen plasma and recombinant-activated factor VII) are poorly aligned with recommended guidelines. Greater efforts to implement current evidence-based transfusion practices are needed. - Crit Care Med 2014
39 Tranexamic Acid Anti-fibrinolytic that inhibits the activation of plasminogen to plasmin, thus decreasing the degradation of fibrin. Tranexamic acid has 8X the activity of ε-aminocaproic acid. Benefit in military setting (Arch Surg 2012) No benefit in urban trauma center (J Trauma 2014) Use in pediatric ENT, CV and Ortho surgery No studies in injured children
40 Recombinant Factor VIIa Dilution/Stored blood products Clot promotion; Activate FXa Effective during hypothermia Thromboelastography (Ped Crit Care Med 2009) Last ditch administration is futile Thrombo-embolic risk?
41 Safety and Efficacy of rfviia in Refractory Traumatic Hemorrhage - J Trauma 2010 CONTROL randomized Phase 3 Trial 573 pts; 4-8 PRBC in 12 hours End-point futility due to low mortality rfviia reduced blood product use but no affect on mortality
42 Recombinant Factor VIIa Vick and Islam; JPS children with Grade III-IV injury Used in NOM; all but 1 transfused micrograms/kg No adverse thromboembolic events
43 Damage Control Topics When / How / Where? Physiology Hemorrhage Abdominal Wall
44 Damage Control Abdominal Wall Temporary expansion Facilitate re-exploration Abdominal compartment syndrome
45 Temporary Abdominal Wall Closure
46 Temporary Abdominal Wall Closure
47 Temporary Abdominal Wall Closure
48 Temporary Abdominal Wall Closure
49 Temporary Abdominal Wall Closure
50 Temporary Abdominal Wall Closure VAC results in lower volume reserve capacity and increased risk of recurrent IAH J Trauma April 2009
51 Abdominal Compartment Syndrome Sequelae Cardiovascular Pulmonary Renal Occult GI - J Trauma 2009
52 Abdominal Compartment Syndrome in Children Neville, et al; JPS patients (NEC, trauma) FiO 2 : 0.87 to 0.67; p<0.01 PIP: 33 to 27; p<0.01 Survival: 65%
53 Damage Control Summary Emphasis on physiologic/metabolic state Must be employed prior to irreversible shock Systematic, staged, multi-disciplinary approach Represents advanced surgical/trauma care!
54
55
56
57 Pediatric Trauma in US Leading cause of death in children > 1 year 22,000 deaths/year (age < 14 y) 600,000 hospitalizations/year 1 in 4 children require emergency visit Cost > $5 billion/year
Plumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department!
Plumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department! EMS Section Chief! Department of Emergency Medicine! University of Missouri-Kansas
Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies
Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and
The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
Dr Anne Weaver London s Air Ambulance CODE RED THE BLEEDING PATIENT
Dr Anne Weaver London s Air Ambulance CODE RED THE BLEEDING PATIENT Objectives Describe the background to Code Red Describe our Standard Operating Procedure Share our data The bleeding problem Major haemorrhage
HEMS in an urbansetting. Anne Weaver RESUS 2013, Limerick 27 th April 2013
HEMS in an urbansetting Anne Weaver RESUS 2013, Limerick 27 th April 2013 Car at night 12 minutes by air 40 minutes by road 10 million people 25 mile radius London HEMS Pan London service Operates as
United States Department of Transportation National Highway Traffic Safety Administration Paramedic: National Standard Curriculum 1
UNIT TERMINAL OBJECTIVE 4-8 At the completion of this unit, the paramedic student will be able to integrate pathophysiologic principles and the assessment findings to formulate a field impression and implement
New Anticoagulants: When and Why Should I Use Them? Disclosures
Winship Cancer Institute of Emory University New Anticoagulants: When and Why Should I Use Them? Christine L. Kempton, MD, MSc Associate Professor of Pediatrics and Hematology and Medical Oncology Hemophilia
Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute
Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical
Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting
To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).
MANAGEMENT OF BLEEDING IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To assist clinicians
Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services
Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know Ronald Walsh, MD Chief Medical Officer Community Blood Services HEMOSTATIC PROCESS Initiation and formation of the platelet plug
PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
Disclosure. Outline. Objectives. I have no actual or potential conflict of interest in relation to this presentation.
Disclosure I have no actual or potential conflict of interest in relation to this presentation. Sarah Lombardo, MD., MSc. General Surgery, University of Utah September 9, 2015 Objectives Outline Recognize
Chapter 6. Hemorrhage Control UNDER FIRE KEEP YOUR HEAD DOWN
Hemorrhage Control Chapter 6 Hemorrhage Control The hemorrhage that take[s] place when a main artery is divided is usually so rapid and so copious that the wounded man dies before help can reach him. Colonel
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013 Anticoagulants Anticoagulants are agents that prevent the formation of blood clots. Before we can talk about
- Lessons from SHOT Haemorrhage cases
- Lessons from SHOT Haemorrhage cases Tony Davies Patient Blood Management Practitioner SHOT / NHSBT Patient Blood Management Team SHOT Annual Symposium 2013 For action by Trusts by April 2011 Decision
Session Number 405 CERTIFICATION REVIEW: HEMATOLOGY AND IMMUNOLOGY
Session Number 405 CERTIFICATION REVIEW: HEMATOLOGY AND IMMUNOLOGY Eleanor Fitzpatrick, RN, MSN, CCRN Thomas Jefferson University Hospital Philadelphia, PA Content Description This session will provide
Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU
New Agents for Treatment of DVT Disclosure PI Adopt and Amplify trials Mark Oliver, MD, RVT, RPVI,FSVU BMS and Pfizer Speaker VTE Venous Thromboembolism Recognized DVT s New : 170,000 Recurrent : 90,000
Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty
Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor
New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013
New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7
Transfusion Medicine
Transfusion Medicine Chapter 5 Transfusion Medicine Routine Transfusion Therapy Blood products should not be transfused on a unit basis in children Base the volume of transfusion products on weight to
Platelet Review July 2012. Thomas S. Kickler M.D. Johns Hopkins University School of Medicine
Platelet Review July 2012 Thomas S. Kickler M.D. Johns Hopkins University School of Medicine Hemostasis Hemostasis is the process that leads to the stopping of bleeding Hemostasis involves blood vessels,
DVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
Joint Theater Trauma System Clinical Practice Guideline
Page 1 of 32 Joint Theater Trauma System Clinical Practice Guideline DAMAGE CONTROL RESUSCITATION AT LEVEL IIb/III TREATMENT FACILITIES Original Release/Approval 18 Dec 2004 Note: This CPG requires an
Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery
Stop the Bleeding: Management of Drug-induced Coagulopathy Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Objectives Discuss contemporary management of warfarin reversal in patients
Recommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
Aehlert: Paramedic Practice Today PowerPoint Lecture Notes Chapter 50: Abdominal Trauma
Aehlert: Paramedic Practice Today PowerPoint Lecture Notes Chapter 50: Abdominal Trauma Chapter 50 Abdominal Trauma 1 Describe the epidemiology, including morbidity, mortality rates, and prevention strategies,
The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
Types of Bariatric Procedures. Tejal Brahmbhatt, MD General Surgery Teaching Conference April 18, 2012
Types of Bariatric Procedures Tejal Brahmbhatt, MD General Surgery Teaching Conference April 18, 2012 A Brief History of Bariatric Surgery First seen in pts with short bowel syndrome weight loss First
Guideline Statement for the Treatment of Disseminated Intravascular Coagulation
Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Introduction Though a rare occurrence in the perioperative setting, disseminated intravascular coagulation (DIC) is a syndrome
Endoscopic Treatment of Bleeding Peptic Ulcers Panagiotis Katsinelos, MD, PhD
Endoscopic Treatment of Bleeding Peptic Ulcers Panagiotis Katsinelos, MD, PhD Department of Endoscopy and Motility Unit G. Gennimatas General Hospital of Thessaloniki Endoscopic diagnosis for UGI bleeding
ABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy. Case Series
ABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy Case Series Summary of Cases: USER EXPERIENCE The ABThera OA NPT system was found by surgeons to be a convenient and effective
Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center
Modified Early Warning Score (MEWS) Ruchika D. Husa, MD, MS Assistant t Professor of Medicine i in the Division of Cardiology The Ohio State University Wexner Medical Center MEWS Simple physiological scoring
Blood products and pharmaceutical emergencies
Blood products and pharmaceutical emergencies Kasey L. Bucher PharmD, BCPS Clinical Specialist, Emergency Medicine Mercy Health Saint Mary s September 12, 2013 Disclosures None significancemagazine.com
TRAUMA SURGERY Dr. Michal Cheatham Orlando Regional Health PGY-4
ROTATION LIAISON: INSTITUTION: LEVEL(S): TRAUMA SURGERY Dr. Michal Cheatham Orlando Regional Health PGY-4 I. GENERAL INFORMATION The General Surgery Department at Orlando Regional Health has three full
KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE (GEN. ORG.) NURSING AFFAIRS. Scope of Service PEDIATRIC INTENSIVE CARE UNIT (PICU)
PICU-Jan.2012 Page 1 of 7 Number of Beds: 18 Nurse Patient Ratio: 1:1-2 : The Pediatric Intensive Care Unit (PICU) provides 24 hour intensive nursing care for patients aged neonate through adolescence.
How To Teach An Integrated Ultrasound
University of South Carolina School of Medicine Integrated Ultrasound Curriculum iusc Richard Hoppmann The Integrated Ultrasound Curriculum Initiated 2006 First (M1) and Second (M2) Year Medical Students
Consent for Treatment/Procedure Laparoscopic Sleeve Gastrectomy
Patient's Name: Today's Date: / / The purpose of this document is to confirm, in the presence of witnesses, your informed request to have Surgery for obesity. You are asked to read the following document
Trauma anaesthesia and critical care: the post trauma network era
: the post trauma network era Sohini Sengupta MBBS MRCP FRCA Peter Shirley FRCA FIMC.RCSEd FFICM EDIC Matrix reference 2A02, 3A10 Key points Trauma should be managed in networks with a major trauma centre
News Release. Media contacts: Ernie Knewitz Tel: 908.927.2953 Mobile: 917.697.2318 [email protected]
News Release Media contacts: Ernie Knewitz Tel: 908.927.2953 Mobile: 917.697.2318 [email protected] Shaun Mickus Phone: 908.927.2416 Mobile: 973.476.7144 [email protected] Investor contacts: Stan
New Oral Anticoagulants
New Oral Anticoagulants Tracy Minichiello, MD Associate Professor of Medicine Chief, San FranciscoVA Anticoagulation and Thrombosis Service Ansell, J. Hematology Copyright 2010 American Society of Hematology.
Imaging of Thoracic Endovascular Stent-Grafts
Imaging of Thoracic Endovascular Stent-Grafts Tariq Hameed, M.D. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana Disclosures: No relevant financial
STUDY GUIDE 1.1: NURSING DIAGNOSTIC STATEMENTS AND COMPREHENSIVE PLANS OF CARE
STUDY GUIDE 1.1: NURSING DIAGNOSTIC STATEMENTS AND COMPREHENSIVE PLANS OF CARE WHAT IS A NURSING DIAGNOSIS? A nursing diagnosis is a clinical judgment about individual, family, or community responses to
Endoscopic therapy for obesity and complications of bariatric surgery
Endoscopic therapy for obesity and complications of bariatric surgery Jacques Devière, MD, PhD Erasme University Hospital Brussels Belgium [email protected] Obesity Affects 300 millions
AVANCOS no TRATAMENTO da HEMORRAGIA MACICA
AVANCOS no TRATAMENTO da HEMORRAGIA MACICA Sandro Rizoli, MD PhD FRCSC FACS Professor Associado Cirurgia & Medicina Intensiva De Souza Trauma Research Chair Chefe Regiao XII Comite de Trauma Colegio Americano
Sepsis: Identification and Treatment
Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge
SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES
SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES TABLE OF CONTENTS SUBJECT PAGE ADULT CRITERIA Red Blood Cells/Autologous 2 Washed Red Blood Cells 2 Cryoprecipitate
Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
Rivaroxaban A new oral anti-thrombotic Dr. Hisham Aboul-Enein Professor of Cardiology Benha University 12/1/2012
Rivaroxaban A new oral anti-thrombotic Dr. Hisham Aboul-Enein Professor of Cardiology Benha University 12/1/2012 Agenda Ideal anticoagulant. Drawbacks of warfarin. Rivaroxaban in clinical trails. Present
Cirrhosis and Coagulation A Paradigm of Awareness. 2014 Robert G. Gish MD
Cirrhosis and Coagulation A Paradigm of Awareness 2014 Robert G. Gish MD None relevant Disclosures: The Clotting Process Initiation and formation of the platelet plug Propagation of the clotting process
Chapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock
Chapter 16 Shock Learning Objectives Explain difference between compensated and uncompensated shock Differentiate among 5 causes and types of shock: Hypovolemic Cardiogenic Neurogenic Septic Anaphylactic
MANAGING BLEEDING IN THE
MANAGING BLEEDING IN THE SETTING OF NEW ANTICOAGULANTS: HOW DO OLD METHODS MEASURE UP? Michelle Zeller MD Clinical Hematology Fellow November 5th, 2011 A FRIDAY NIGHT ON-CALL WITH DR. B. LUD Very keen
IVTMTM Intravascular Temperature
IVTMTM Intravascular Temperature Management T e m p e r a t u r e i s V i t a l Intravascular Temperature Management (IVTM) Temperature Management Is Vital to Life Temperature is one of the four main vital
Clinical Guideline N/A. November 2013
State if the document is a Trust Policy/Procedure or a Clinical Guideline Clinical Guideline Document Title: Document Number 352 Version Number 1 Name and date and version number of previous document (if
Critical Bleeding Reversal Protocol
Critical Bleeding Reversal Protocol Coagulopathy, either drug related or multifactorial, is a major contributing factor to bleeding related mortality in a variety of clinical settings. Standard therapy
ABOUT XARELTO CLINICAL STUDIES
ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the
Cancer and the Heparins
WP Ceelen, MD, PhD Department of GI Surgery - UZ Gent Senior Clinical Researcher - FWO Overview Mechanisms of cancer induced thrombosis Guidelines for prevention and treatment of VTE in cancer patients
Elisabetta Toso, MD Dipartment of Medical Sciences University of Turin
Security and efficacy of Rivaroxaban in real life in the prevention of the stroke in non valvular AF patients: presentation of the results of the international study Xantus Elisabetta Toso, MD Dipartment
Directed to Dr. Carrier from NBRHC audience Q: In patients with GI Bleed history, would you suggest Apixaban for newly diagnosed patients
9 th Annual CBS/ORBCoN Transfusion Medicine Videoconference Symposium: April 9, 2014 Question and Answer Period Morning Session: Directed to Dr. Carrier from Dr. Bormanis Q: If the half lives are similar
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives
Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology
Patient Blood Management Guidelines: Module 4. Critical Care
Patient Blood Management Guidelines: Module 4 Critical Care National Blood Authority, 2012. With the exception of any logos and registered trademarks, and where otherwise noted, all material presented
Policies and Procedures. Related to. IABP Therapy
Policies and Procedures Related to IABP Therapy Courtesy of Datascope Corp. Clinical Support Services The following policies and procedures are intended to serve as guidelines for developing hospital policy.
Benefit Criteria to Change for Hyperbaric Oxygen Therapy for the CSHCN Services Program Effective November 1, 2012
Benefit Criteria to Change for Hyperbaric Oxygen Therapy for the CSHCN Services Program Effective November 1, 2012 Information posted September 14, 2012 Effective for dates of service on or after November
Open Ventral Hernia Repair
Ventral Hernias Open Ventral Hernia Repair UCSF Postgraduate Course in General Surgery Maui, HI March 21, 2011 Hobart W. Harris, MD, MPH Ventral Hernias: National Experience Occur following 11-23% of laparotomies,
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatment
Gruppo di lavoro: Malattie Tromboemboliche
Gruppo di lavoro: Malattie Tromboemboliche 2381 Soluble Recombinant Thrombomodulin Ameliorates Hematological Malignancy-Induced Disseminated Intravascular Coagulation More Promptly Than Conventional Anticoagulant
Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi
Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the
GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY
BLOOD CONSERVATION STRATEGIES IN CARDIAC SURGERY: MORE IS BETTER GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY DIMITRIOS V. AVGERINOS MD, PhD, FACS, FACC Department of Cardiac Surgery,
Point-of-care testing Thrombelastography and platelet transfusion
Point-of-care testing Thrombelastography and platelet transfusion Gisela Scharbert Department of Anesthesiology, Intensive Care and Pain Management Vienna Medical University, Austria Trauma-induced coagulopathy
Thrombin Formation for Children on Lovenox. Steven Ignell, BA
Thrombin Formation for Children on Lovenox Steven Ignell, BA Definitions Anticoagulation Historically this refers to inhibiting thrombin formation Measured by PTT, INR, anti-xa Hypo and hypercoagulation
Hemostasis analyzer system
Hemostasis analyzer system Providing fast, actionable results to help you reduce risks, complications and costs Get the whole picture with TEG Hemostasis analyzer system For more than forty years, hospitals
Advances in Trauma Resuscitation: Implications for the Nurse Anesthetist
Advances in Trauma Resuscitation: Implications for the Nurse Anesthetist Caleb A. Rogovin, CRNA, MS, CCRN, CEN Assistant Director Nurse Anesthesia Program University of Maryland School of Nursing Trauma
USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)
USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals:
Conserva)ve Treatment of PE/ DVT
Conserva)ve Treatment of PE/ DVT Amir Kaki, MD FACC FSCAI Asst Prof of Medicine Wayne St SOM Medical Director Cardiac Catheteriza)on Lab Heart Hospital DMC Detroit, MI Incidence Acute pulmonary embolism
New anticoagulants: Monitoring or not Monitoring? Not Monitoring
The 2 nd World Congress on CONTROVERSIES IN HEMATOLOGY (COHEM) Barcelona, Spain September 6 8, 2012 New anticoagulants: Monitoring or not Monitoring? Not Monitoring Anna Falanga, MD Immunohematology and
Role of the Medical Director
Role of the Medical Director Beth Shaz, MD Assistant Professor, Emory University School of Medicine Director, Transfusion Services, Grady Memorial Hospital Atlanta, GA 1.1.1 Medical Director Responsibilities
1 1-1 1-1 All trauma centers must participate in the state and/or regional trauma system planning, development, or operation.
American College of Surgeons Consultation/Verification Program Reference Guide of Suggested Classification Level II Chapter CD Requirement by Chapter http://www.facs.org/trauma/verifivisitoutcomes.html
Adult Inpatient/Emergency Department Procoagulant Clinical Practice Guideline (CPG) Cover Sheet
Adult Inpatient/Emergency Department Procoagulant Clinical Practice Guideline (CPG) Cover Sheet Target Population: Adult inpatients and emergency department patients with sustained bleeding requiring administration
ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head
ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION
Definitive Surgical Trauma Care-DSTC
EUROPEAN SOCIETY FOR TRAUMA AND EMERGENCY SURGERY (ESTES) & INTERNATIONAL ASSOCIATION FOR THE SURGERY OF TRAUMA AND SURGICAL INTENSIVE CARE (IATSIC) DEPARTMENT OF SURGERY MEDICAL UNIVERSITY OF GRAZ WORKSHOP
APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES
APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES The critical care nurse practitioner orientation is an individualized process based on one s previous experiences and should
Gastrointestinal bleeding
Gastrointestinal bleeding..is the reason in 2 % of all admissions to hospital 85.000 cases/year in the US. The incidence of urgent upper GI bleeding: 145/100.000 inhabitant/year in Hungary ( Nagy Gy. MBA
Surgical Site Infection Prevention
Surgical Site Infection Prevention 1 Objectives 1. Discuss risk factors for SSI 2. Describe evidence-based best practices for SSI prevention 3. State principles of antibiotic prophylaxis 4. Discuss novel
Recommendations on Use of Dabigatran in Atrial Fibrillation
Recommendations on Use of Dabigatran in Atrial Fibrillation Developed by participants from the Section of Hematology/Oncology and Section of Cardiology, and Faculty of Pharmacy, University of Manitoba
Non-surgical treatment of severe varicose veins
Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in
TITLE 836 INDIANA EMERGENCY MEDICAL SERVICES COMMISSION. ARTICLE 1.5 Trauma Field Triage and Transport Destination Requirements
TITLE 836 INDIANA EMERGENCY MEDICAL SERVICES COMMISSION ARTICLE 1.5 Trauma Field Triage and Transport Destination Requirements 836 IAC 1.5-1 Purpose Affected: [IC 10-14-3-12; IC 16-18; IC 16-21-2; IC 16-31-2-9;
Clinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
Guidelines for diagnosis and management of acute pulmonary embolism
Guidelines for diagnosis and management of acute pulmonary embolism By Dr. Ahmed Zaghloul M.D. Anesthesia & Critical Care 2014 Predisposing factors for VTE Predisposing factor Strong predisposing factors
Improving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting
Improving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting DATE Educating for Quality Improvement & Patient Safety 1 The Team Division CS&E Participants
